Skip to content

Clinical trials

Observational Hypertension trials in Nigeria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Observational Country / region: Nigeria Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20171
20182
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Healthsystem Plus1
Imperial College London1
Indiana University1
National Human Genome Research Institute (NHGRI)1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Renaissance University Ugbawka, Enugu1
University of Abuja1
University of Ibadan1
University of Leeds1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension10
Diabetes Mellitus2
Renal Insufficiency, Chronic2
Acute Kidney Injury1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Dyslipidemias1
Edema1
Heart Failure1
Obesity1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.